Exclusive: Highlander Health, co-led by Amy Abernethy, is born

Also: A race-free algorithm is merely the start for a safety net hospital confronting an onslaught of kidney disease

September 10, 2024 Check out STAT+

Sponsored By

Courtesy Highlander Health STAT+ | Former Verily executives hatch plan to invest millions in high-tech medical data Amy Abernethy and Brad Hirsch aim to lower the cost of conducting clinical trials and speed medical progress through their new venture, Highlander Health. By Matthew Herper STAT+ | Roivant acquires drug for pulmonary hypertension from Bayer The company believes that mosliciguat, administered once per day using a dry powder inhaler, will help fill "an unmet medical need." By Adam Feuerstein A race-free algorithm is merely the start for a safety net hospital confronting an onslaught of kidney disease STAT series "Embedded Bias" examines impact of removing race from a medical algorithm at a hospital facing a kidney disease epidemic. By Usha Lee McFarling Marshall Ritzel/AP Key lawmakers are wary of giving FDA more cash to crack down on e-cigs The situation presents a Catch-22 for the FDA, which says it needs more funds to police illegal vapes. By Nicholas Florko STAT+ | Pharma is still struggling to widen access to medicines — and reach patients — in low- and middle-income countries "There's a big gap between what the companies say and what they do," said Jayasree Iyer, who heads the Access to Medicines Foundation. By Ed Silverman Q&A: Atsena Therapeutics' gene therapy for inherited blindness shows promise Study participants' vision improved and lasted for the duration of the study (12 months), with no serious side effects. By Timmy Broderick Adobe STAT+ | Viridian drug achieves study goals as treatment for thyroid eye disease The drug achieved its primary goals in a Phase 3 clinical trial and compared favorably to a similar drug already approved and sold by Amgen.  By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser